NGNE vs TYL · $286.5M cap vs P/E 89, rev $1.26B
Neurogene Inc (NGNE) versus Tyler Technologies Inc (TYL) — a side-by-side from cached financials, not a winner call.
Neurogene Inc (NGNE) is a biotechnology company listed on US.
Tyler Technologies Inc (TYL) is a software - application company listed on US.
Latest reported NGNE revenue for 2025-09-30 was $0. Net income was -$21.0M. NGNE currently screens at market cap $286.5M.
Latest reported TYL revenue for 2026-06-30 was $1.26B. Net income was $174.7M. TYL currently screens at market cap $25.57B and trailing P/E 89.3.
NGNE currently screens at market cap $286.5M. TYL currently screens at market cap $25.57B and trailing P/E 89.3.
Not investment advice. Open the NGNE and TYL stock pages for the full models.
Not investment advice.